Spartalizumab in Combination With Dabrafenib And Trametinib in Advanced BRAF V600–Mutant Melanoma: Efficacy, Safety, and Biomarker Findings in Parts 1 and 2 of COMBI-i
Year: 2020
Type: article
Authors: Reinhard Dummer, Célèste Lebbé, Victoria Atkinson, Mario Mandalà, Paul Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf, Hussein A. Tawbi, Paolo A. Ascierto, Antoni Ribas, Keith T. Flaherty, Neha Pakhle, Katie M. Campbell, Daniel Gusenleitner, Aisha Masood, Jan C. Brase, Eduard Gasal, Georgina V. Long
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3108224982
FWCI:
Cites:
Cited by:
Related to: